TRPM7 activates the JAK2/STAT3 signaling pathway leading to glioma aggravation [79,81], as there is crosstalk between this pathway and ALDH1 and CD133, two glioma stemness markers, suggesting a role of TRPM7 in glioma stem cells [81]. This evidence concerns the gene JAK2 and central nervous system cancer.